STOCK TITAN

AEHR TEST SYSTEMS (AEHR) director-linked trust sells 5,973 common shares at $140

(High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

AEHR TEST SYSTEMS director Rhea J. Posedel, through a trust, reported selling 5,973 shares of common stock on 2026-08-14 in a sale described as an open market or private transaction at $140.00 per share. After this sale, the trust holds 381,989 indirect shares, and a separate line shows 47,156 direct shares, which include shares subject to unvested restricted stock units.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider POSEDEL RHEA J
Role Director
Sold 5,973 shs ($836K)
Type Security Shares Price Value
Sale Common Stock 5,973 $140.00 $836K
holding Common Stock F1 -- -- --
Holdings After Transaction: Common Stock — 381,989 shares (Indirect, By Trust); Common Stock — 47,156 shares (Direct)
Footnotes (1)
  1. F1. The amount reported includes shares subject to unvested restricted stock units.
Shares sold 5,973 shares Common Stock sold indirectly by trust on 2026-08-14
Sale price $140.00 per share Price for 5,973 AEHR common shares sold on 2026-08-14
Indirect holdings after sale 381,989 shares Common Stock held indirectly "By Trust" following the sale
Direct holdings after transaction 47,156 shares Directly held Common Stock including unvested restricted stock units
indirect ownership financial
"The sale is reported as indirect ownership with nature of ownership "By Trust""
restricted stock units financial
"The amount reported includes shares subject to unvested restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open market or private transaction financial
"Transaction code description notes a sale in open market or private transaction."

FAQ

What insider transaction did AEHR (AEHR) report for Rhea J. Posedel?

AEHR TEST SYSTEMS reported that director Rhea J. Posedel, via a trust, sold 5,973 shares of common stock on 2026-08-14 in a sale characterized as an open market or private transaction.

At what price were the AEHR (AEHR) shares sold by the trust associated with Rhea J. Posedel?

The trust associated with Rhea J. Posedel sold 5,973 AEHR shares at $140.00 per share. This price is reported on the non-derivative transaction line describing a sale in an open market or private transaction.

How many AEHR (AEHR) shares does the trust hold after the reported sale?

Following the sale, the trust associated with Rhea J. Posedel holds 381,989 shares of AEHR common stock as indirect ownership. This post-transaction amount is labeled as held "By Trust" in the filing data.

What are Rhea J. Posedel’s direct AEHR (AEHR) holdings after the transaction?

Separate from the trust, Rhea J. Posedel is shown with 47,156 shares of AEHR common stock held directly. A footnote explains this amount includes shares subject to unvested restricted stock units.

Was the AEHR (AEHR) insider sale by Rhea J. Posedel made under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked as affirming a trading plan for these transactions. No footnote states that the reported sale occurred pursuant to a Rule 10b5-1 plan.

Is the AEHR (AEHR) sale by Rhea J. Posedel a direct or indirect ownership transaction?

The sale of 5,973 shares is reported as indirect ownership with the nature of ownership specified as "By Trust." Direct holdings are reported separately and were not part of this sale line.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
POSEDEL RHEA J

(Last)(First)(Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CALIFORNIA 94539

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
Director
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/14/2026S5,973D$140381,989IBy Trust
Common Stock47,156(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/Chris Siu, Attorney-in-Fact08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)